Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitors
- 31 October 1993
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 22 (2-3), 131-141
- https://doi.org/10.1016/0166-3542(93)90091-v
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse TranscriptaseVirology, 1993
- 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitorsAntimicrobial Agents and Chemotherapy, 1992
- Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsAntimicrobial Agents and Chemotherapy, 1992
- A synthesis of various substituted naphthalenones by additions to naphthyloxazolinesThe Journal of Organic Chemistry, 1992
- Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesisVirology, 1992
- HIV Inhibitors Targeted at the Reverse TranscriptaseAIDS Research and Human Retroviruses, 1992
- Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric templateNucleic Acids Research, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element regionCell, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989